Abiopharma

🔍 Shah Dharmesh (Executive)

Company: HUBSPOT INC (HUBS)

Report Date: 2026-05-12

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $181.37 per share (Direct)
  Date: 2026-05-12 | Code: P | equity_swap_involved: false | shares_owned_after: 1,295,400.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-12 | Code: H | nature_of_ownership: See Footnote. | shares_owned_after: 16,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-12 | Code: H | nature_of_ownership: See Footnote. | shares_owned_after: 11,000.00 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $181.13 to $182.10, inclusive. The reporting person undertakes to provide to HubSpot, Inc., any security holder of HubSpot, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
• F2: Shares held by the Polaris I Trust, for which Dharmesh Shah serves as trustee. The reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F3: Shares held by the Polaris II Trust, for which Dharmesh Shah serves as trustee. The reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.